AquaBounty Technologies to Present at the June 2020 Virtual Investor Summit

Rhea-AI Summary

AquaBounty Technologies (NASDAQ: AQB) will present at the June 2020 Virtual Investor Summit from June 9-12, 2020. Management's presentation is scheduled for June 10 at 2:10 p.m. ET. The event will showcase AquaBounty's advancements in land-based aquaculture, aiming to enhance sustainability and productivity. The company is recognized for its AquAdvantage salmon, which has received FDA and Health Canada approval as a bioengineered protein. The presentation is public, but one-on-one meetings require an invitation and advance registration.

News Market Reaction – AQB

+1.84%

1 alert

+1.84% News Effect

On the day this news was published, AQB gained 1.84%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

MAYNARD, Mass., June 03, 2020 (GLOBE NEWSWIRE) -- AquaBounty Technologies, Inc. (NASDAQ: AQB) (“AquaBounty” or the “Company”), a land-based aquaculture company utilizing technology to enhance productivity and sustainability, today announced that management will present at the June 2020 Virtual Investor Summit being held on June 9-12, 2020.

AquaBounty management will host virtual one-on-one investor meetings throughout the event and is scheduled to present as follows:

Virtual Investor Summit
Date: Wednesday, June 10, 2020
Time: 2:10 p.m. Eastern time (11:10 a.m. Pacific time)
Webcast: https://www.webcaster4.com/Webcast/Page/2038/35133

Management’s presentation will be open to the public, but participation in the one-on-one investor meetings is by invitation only. In either case, advance registration is required. For more information, or to schedule a virtual one-on-one meeting, please contact a conference representative at info@investorsummitgroup.com.

About AquaBounty Technologies, Inc.

AquaBounty Technologies, Inc. (NASDAQ: AQB) is a commercial aquaculture company focused on improving efficiency, sustainability, and profitability, leveraging decades of biotechnology expertise to ensure the availability of high-quality seafood to meet global consumer demand. Both the U.S. Food and Drug Administration and Health Canada approved the Company’s AquAdvantage salmon as the first and only bioengineered animal protein for human consumption.

The Company’s AquAdvantage fish program is based upon a single, specific molecular modification that results in more rapid growth during early development, resulting in a 70 percent increase in annual production output for AquAdvantage versus conventional Atlantic salmon. With aquaculture facilities located in Indiana and on Prince Edward Island, AquaBounty is raising its disease-free, antibiotic-free salmon in land-based Recirculating Aquaculture Systems, resulting in a reduced carbon footprint and no risk of pollution to marine ecosystems as compared to traditional sea-cage farming. For more information, please visit www.aquabounty.com.

Investor Relations

Greg Falesnik
Managing Director
MZ Group - MZ North America
(949) 385-6449  
AQB@mzgroup.us
www.mzgroup.us

FAQ

When is AquaBounty scheduled to present at the June 2020 Virtual Investor Summit?

AquaBounty is scheduled to present on June 10, 2020, at 2:10 p.m. Eastern time.

What is the significance of AquaBounty's AquAdvantage salmon?

AquAdvantage salmon is the first bioengineered animal protein approved for human consumption by the FDA and Health Canada.

How does AquaBounty enhance sustainability in aquaculture?

AquaBounty uses land-based Recirculating Aquaculture Systems, reducing the carbon footprint and pollution risks associated with traditional farming.

What are the dates for the June 2020 Virtual Investor Summit?

The summit will take place from June 9-12, 2020.

How can investors participate in AquaBounty's one-on-one meetings during the summit?

Participation in one-on-one meetings is by invitation only, and advance registration is required.